Browsing Tag
Exelixis
4 posts
Will CABOMETYX secure EU approval for advanced neuroendocrine tumors after CHMP’s positive opinion?
Ipsen’s CABOMETYX receives EMA's CHMP backing for advanced neuroendocrine tumors; EU approval expected in 2025 following FDA nod.
Wall Street bets on biotech and AI: Reddit, Exelixis, Rocket Lab all explode
U.S. stock market top gainers on May 14, 2025: See why Newegg, Rigetti, Reddit, and Exelixis surged as investor sentiment turned risk-on. Read full analysis.
FDA approves Opdivo and Cabometyx combo for advanced kidney cancer treatment
The U.S. Food and Drug Administration (FDA) has officially approved the combination of Bristol Myers Squibb’s Opdivo (nivolumab)…
COSMIC-311 clinical trial : Exelixis enrolls patients to study cabozantinib in phase 3 thyroid cancer trial
COSMIC-311 clinical trial : US biotech company Exelixis has enrolled the first 100 patients in a phase 3…